Monday, November 12, 2007
will infant formula's be able to inhibit bacteria?
Bristol Myers Squibb (Mead Johnson) has a patent application that is called "Methods for inhibiting the growth of bacteria." It is application number 20070191264 and the inventors are Robert J. McMahon et al. It was filed in 2005. They plan to add bovine lactoferrin to infant formula. Since cow's have little or no lactoferrin, we might ask what exactly are they adding to infant formula? We can get human lactoferrin from transgenic cows (cloned milk). Cloned milk and meat have been accepted by the FDA for use in the marketplace. The FDA does not accept the word bovine lactoferrin and instead calls it milk lactoferrin. So one might come to the conclusion that this company has the intention of using a cloned product to inhibit bacteria--e.coli.
This pending patent states:
"Diarrhea is a particularly dangerous disease for children and infants. It is the leading cause of death in children under 5 years of age, accounting for 3-4 million deaths each year worldwide."
"Multiple studies have shown that exclusive breastfeeding and to a lesser extent, partial breastfeeding, can protect against acute & persistant diarrhea."
"As a means for protecting children younger than 5 years of age against various diarrheal diseases breastfeeding has been identified as the most effective intervention."
What can one say? Breastfeeding has been identified as the most effective intervention against diarrhea in children under 5 years of age. Thank you Mead Johnson...now if we could only hear this publicly.